Phase 2 Proof-of-Concept Study of the Safety and Efficacy of Alfimeprase to Rapidly Open Arteries and Restore Brain Function Following a Stroke
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Susan M Begelman, MD
ARCA Biopharma, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Calgary, Foothills Medical Centre
Calgary, Alberta, Canada
- Vancouver General Hospital
Vancouver, British Columbia, Canada
- Trilium Health Center
Mississauga, Ontario, Canada
- University Health Network Toronto
Toronto, Ontario, Canada
- Montreal Neurological Institute
Montreal, Quebec, Canada
- Ucla Medical Center
Los Angeles, California, United States
- Northwestern Medical Center
Chicago, Illinois, United States
- Ruan Neurology & Clinical Research Center
Des Moines, Iowa, United States
- University of Iowa Hospital
Iowa City, Iowa, United States
- University of Iowa Hospital
Iowa City, Iowa, United States
- University of Kansas School of Medicine, Via Christi Regional Medical Center
Wichita, Kansas, United States
- Norton Hospital
Louisville, Kentucky, United States
- Michigan State University, Sparrow Hospital
Lansing, Michigan, United States
- Albany Medical Center Hospital
Albany, New York, United States
- Kalieda Health, Mfh
Buffalo, New York, United States
- Columbia Presbyterian Medical Center
New York, New York, United States
- University of Cincinnati
Cincinnati, Ohio, United States
- Riverside Methodist Hospital
Columbus, Ohio, United States
- Oregon Stroke Center
Portland, Oregon, United States
- University of Pittsburg Medical Center
Pittsburgh, Pennsylvania, United States
- Baylor College of Medicine
Houston, Texas, United States
- St. Luke'S Medical Center
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2007
- Primary completion
- 31 May 2008
- Completion
- 31 May 2008
- Last update posted
- 24 Apr 2008
- Registered enrollment
- 7
- Registry id
- NCT00499902
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.